The safety of hydroxyethyl starch use in newborns and its short- and long-term benefits in hypovolemic patients.
Simbruner
George
G
D000367:Age Factors; D000418:Albumins / Q000008:administration & dosage / Q000494:pharmacology; D001802:Blood Substitutes / Q000008:administration & dosage / Q000494:pharmacology*; D002405:Catheterization, Central Venous; D006439:Hemodynamics / Q000187:drug effects; D006801:Humans; D006895:Hydroxyethyl Starch Derivatives / Q000008:administration & dosage / Q000494:pharmacology*; D020896:Hypovolemia / Q000628:therapy; D007231:Infant, Newborn; D007234:Infant, Premature; D007262:Infusions, Intravenous; D015201:Meta-Analysis as Topic; D008970:Molecular Weight; D010865:Pilot Projects; D016032:Randomized Controlled Trials as Topic; D012449:Safety; D013997:Time Factors
D000418:Albumins; D001802:Blood Substitutes; D006895:Hydroxyethyl Starch Derivatives